The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Open accessAbstract
Interleukin (IL)-6 is one of several proinflammatory cytokines that have been associated with insulin resistance and type 2 diabetes. A two- to threefold elevation of circulating IL-6 has been observed in these conditions. Nonetheless, little evidence supports a direct role for IL-6 in mediating insulin resistance. Here, we present data that IL-6 can inhibit insulin receptor (IR) signal transduction and insulin action in both primary mouse hepatocytes and the human hepatocarcinoma cell line, HepG2. This inhibition depends on duration of IL-6 exposure, with a maximum effect at 1-1.5 h of pretreatment with IL-6 in both HepG2 cells and primary hepatocytes. The IL-6 effect is characterized by a decreased tyrosine phosphorylation of IR substrate (IRS)-1 and decreased association of the p85 subunit of phosphatidylinositol 3-kinase with IRS-1 in response to physiologic insulin levels. In addition, insulin-dependent activation of Akt, important in mediating insulin's downstream metabolic actions, is markedly inhibited by IL-6 treatment. Finally, a 1.5-h preincubation of primary hepatocytes with IL-6 inhibits insulin-induced glycogen synthesis by 75%. These data suggest that IL-6 plays a direct role in insulin resistance at the cellular level in both primary hepatocytes and HepG2 cell lines and may contribute to insulin resistance and type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with previous studies that indicate IL-6 promotes hepatic insulin resistance through IL-6/STAT3induced inhibition of insulin receptor signaling 18,45,46”
From Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis (2024) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“genes reported to be involved in hepatic insulin resistance, including Il6 45-48 , Spp1 49,50 and Igfbp1 51”
From Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis (2024) · cites this paper as [45]
In the citing paper
“In cultured hepatocytes (25)(26)(27)(28), preadipocytes, and mature adipocytes (29), IL-6 directly impairs insulin action.”
From Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle (2006) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,246
Cited by
Sorted by citations
Items 701–800 of 879
Inflammation métabolique et insulino-résistance : Les connaissances actuelles
Dali‐Youcef, N. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30075-4 · Cited by 3
The IGF-IGFBP system in aerobic exercise : with focus on skeletal muscle
Berg, U. (2007) · Figshare · Cited by 1
Park, C. H., Lee, J. Y., Shin, S. H., Kim, M. Y., Lee, E. S., Shin, Y. S., Kim, Y. O., Lee, S., Choi, J. S., & Yokozawa, T. (2017) · Preprints.org · doi:10.20944/preprints201705.0208.v1 · Cited by 2
“Furthermore, some studies have shown that TNF-α and IL-6 are positively correlated with measures of insulin resistance and/or plasma insulin concentration [35,36].”
BackgroundThyroid Dysfunction and Cardiovascular Disease in Chronic Kidney Disease
Zoccali, C., & Mallamaci, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_24 · Cited by 1
Qian, S., Liu, Y., Wang, W., Ni, W.-J., Zhao, S., Xu, Y., Gu, P., Yu, W., & Tong, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1501530 · Cited by 2
Shi, H., Liu, Q., Zhong, L., Zhou, M., Zhang, T., & Lei, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-47165-7 · Cited by 1
Zhou, S., Hu, W., Kan, J., Zalán, Z., Chengjun, J., & Du, M. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108974 · Cited by 1
Le tissue adipeux: Son rôle dans les maladies métaboliques
Pégorier, J. P. (2007) · Springer eBooks · doi:10.1007/978-2-287-33475-7_25 · Cited by 1
Mood Disorders and Cardiovascular Disease
Jennifer, L., Lavoie, K., Arsenault, A., Ditto, B., & Simon, L. S. (2012) · InTech eBooks · doi:10.5772/33278 · Cited by 1
“Adipokines also contribute to obesity-induced insulin resistance by inhibiting insulin’s signal to fat and muscle cells to absorb glucose (Senn et al., 2002; Uysal et al., 1997).”
BackgroundNowe adipokiny - korzystne czy niekorzystne w aspekcie patogenezy insulinooporności?
Olszanecka‐Glinianowicz, M., Kocełak, P., Orlik, B., Handzlik, G., & Juszczyk, Ł. (2009) · Via Medica Journals · Cited by 1
Adipokines in Health and Disease
Ahima, R. S., & Goncalves, M. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_4 · Cited by 1
Effects of synbiotic Gaz consumption on insulin function and serum hs-CRP in pregnant women
Bahmani, F., Asemi, Z., Taghizadeh, M., Khassaf, A., & Alizadeh, S. (2014) · The Journal of Qazvin University of Medical Sciences · Cited by 1
Taghdir, M., Djazayeri, A., Sepandi, M., Ashourpour, M., Fariba, F., & Djalali, M. (2011) · Journal of Diabetes & Metabolic Disorders · Cited by 1
Wang, Y., Chen, J., Pan, J., Zhang, W., Chen, Z., & Yu, F. (2013) · PubMed · Cited by 1
Exercise ameliorates diabetes-induced osteoarthritis in rats
El-Karib, A. O. (2014) · Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology/Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology · doi:10.21608/eajbsc.2014.16035 · Cited by 1
“…that exercise suppresses the release of the proinflammatory cytokine, IL-6 that is known to be involved in the pathology of diabetes (Suthem et al. 1990; Senn et al. 2002) and OA (Doss et al. 2007; Stannus et al. 2010), we measured, by ELISA, the blood level of IL-6, 8 weeks after T1DM induction.”
BackgroundPathomechanism of insulin resistance in chronic hepatitis C
Kukla, M., Sawczyn, T., Żwirska-Korczala, K., & Jarosz, M. J. (2011) · Gastroenterology Review · doi:10.5114/pg.2011.25376 · Cited by 1
“Przewlekła ekspozycja na zwiększone stężenie IL-6 zmniejsza autofosforylację receptorów insulinowych oraz fosforylację IRS-1 i IRS-2, co przekłada się na wzrost IR [45, 46].”
Biological role of tumor necrosis factor type α in physiology and pathophysiology
Badowska-Kozakiewicz, A. M. (2013) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2013.35071 · Cited by 1
Kim, M., & Wands, J. R. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_15 · Cited by 1
Ren, J., Wang, X., Nakao, T., Libby, P., & Shi, G. (2023) · Cardiology Discovery · doi:10.1097/cd9.0000000000000096 · Cited by 1
Kumari, A. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005568 · Cited by 1
Neuroendocrine mechanisms of behavioral changes induced by hypoglycemia
Park, M. J. (2010) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 1
Patrizi, R. M. (2008) · University Microfilms International eBooks · Cited by 1
Zhou, Y., Xu, J. C., & Xu, C. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15027596 · Cited by 1
“IL-6 is one of several proinflammatory cytokines that have been associated with insulin resistance (Senn et al., 2002).”
BackgroundLeukocyte Count as Chronic Inflammation Markers in Type 2 Diabetes Patients
Durmuş, E., Aypak, C., & Görpelioğlu, S. (2017) · Ankara Medical Journal · doi:10.17098/amj.364164 · Cited by 1
Mobini, M., Niksolat, F., Mohammadpour, R. A., Sadr, S., & Dargahloo, S. D. (2018) · Rheumatology Research · doi:10.22631/rr.2018.69997.1044 · Cited by 1
“hyperglycemia, compensatory hyperinsulinemia, and dyslipidemia [22,23].”
Dahman, L. S. B., Al‐Daghri, N. M., Alfadda, A. A., Sallam, R. M., & McTernan, P. G. (2020) · doi:10.3390/iecbm2020-08579 · Cited by 1
Zhang, W., Li, Y., Ke, H.-Q., Wang, Y., Duan, C., Zhu, Q., & Liu, H. (2021) · Archives of Medical Science · doi:10.5114/aoms/135595 · Cited by 1
Trocha–Mendoza, M. J., & Arévalo‐Caro, C. (2021) · Acta Odontológica Colombiana · doi:10.15446/aoc.v11n2.95219 · Cited by 1
“En primer lugar, porque niveles elevados de IL-6 se han relacionado con IR y por ende con DM2 (25), y en segundo lugar, porque el TNF-α puede alterar la vía de señalización de insulina y, también, interferir en la secreción de insulina por parte de las células beta pancreáticas (9).”
BackgroundInflammation in chronic kidney disease
Carrero, J. J., Kistler, B. M., & Stenvinkel, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00049-5 · Cited by 1
Universidad Autónoma de Bucaramanga, B., Blanco, E., León, J. S. T., Universidad Autónoma de Bucaramanga, B., Ayala, J. A. G., Universidad Autónoma de Bucaramanga, B., Peña, V. C., Universidad Autónoma de Bucaramanga, B., Strauch, R. G. P., Universidad Autónoma de Bucaramanga, B., et al. (2023) · Revista Salud y Desarrollo · doi:10.55717/dufq2969 · Cited by 1
“55717/DUFQ2969 insulin receptor autophosphorylation, and disrupt signaling pathways leading to hyperglycemia, compensatory hyperinsulinemia, and dyslipidemia (Senn et al., 2002; Gupta et al., 2007).”
BackgroundYang, J. (2009) · Cited by 1
Adipocytokine Dysregulation, Obesity and the Metabolic Syndrome
Smith, U., & Yang, X. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch14 · Cited by 1
Type 2 diabetes exacerbates bone loss in Native American women
Leyva, M. J. (2012) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) · Cited by 1
Bonora, E., Brangani, C., & Pichiri, I. (2008) · Giornale italiano di cardiologia · doi:10.1714/669.7812 · Cited by 1
Wang, Y., Ling-fang, K., Wang, Y., Cao, Y., & Song, Y. (2011) · International Journal of the Physical Sciences · doi:10.5897/ijps11.035 · Cited by 1
Teppo, A. (2005) · Työväentutkimus Vuosikirja · Cited by 1
For Debate Interleukin-6 and insulin sensitivity: friend or foe?
Carey, A. L., & Febbraio, M. A. (2004) · Cited by 1
Al-Qarakhli, A. M. A. (2018) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Ruscitti, P., Sesti, G., Cipriani, P., Gerli, R., & Giacomelli, R. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220047 · Cited by 1
Protein and mRNA Studies of Rat FA1/Pref-1/dlk
Hedlund, G. P. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Al‐Daghri, N. M., Alfadda, A. A., Sallam, R. M., McTernan, P. G., & Dahman, L. S. B. (2021) · Preprints.org · doi:10.20944/preprints202104.0170.v1 · Cited by 1
Kim, M., & Wands, J. R. (2005) · Springer eBooks · doi:10.1007/3-540-27194-5_9 · Cited by 1
COVID-19 and metabolic disorders: focus on the implicated molecular pathwaysPreprint
Nigro, E., Perrotta, F., Polito, R., D’Agnano, V., Scialò, F., Bianco, A., & Daniele, A. (2020) · doi:10.22541/au.158880240.00304700
Vitamin D, Inflammation, and Relations to Insulin Resistance in Morbidly Obese Pre-Menopausal Women
Nguyen, V. T. (2013) · Figshare
Korsheninnikova, E. (2003) · Työväentutkimus Vuosikirja
Pham, R. N., & Do, T. M. N. (2011) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver
Perandini, L. A. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-23102014-144752
Regulation of human adipose tissue gene expression in relation to obesity and insulin resistance
Klimčáková, E. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Glund, S. (2007) · Figshare
Pignalosa, A. (2011) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/8988
Guimarães, D. E. D. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2012.tde-24072012-165034
Lundgren, M. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Resistencia a insulina en el músculo esquelético: conexión con la obesidad
Vázquez, I. N., Fernández‐Veledo, S., García‐Guerra, L., Vila‐Bedmar, R., & Lorenzo, M. (2008) · Anales de la Real Academia Nacional de Farmacia
Fatty acid metabolism, impaired glucose tolerance and the effects of lifestyle
Corpeleijn, E. (2006) · Research Publications (Maastricht University) · doi:10.26481/dis.20061110ec
Kelder, T. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20110708tk
Goldaracena-Azuara, M., Calderón, J., Mendoza, E. D. L. C., Morales, J. M. V., Mondragón-González, R., Cruz, M., Lucina, T.-R. M., & Aradillas-García, C. (2008) · RESPYN Revista de Salud Pública y Nutrición
Molecular mechanisms of insulin resistance in chronic liver disease
Bernsmeier, C. (2008) · edoc (University of Basel) · doi:10.5451/unibas-004634719
“Upregulation of the cytokines IL-6 (136, 143) and TNF (121, 137) in response to viral infection have also been proposed to interfere with the insulin signaling cascade and initiate insulin resistance development.”
BackgroundBariatric surgery and its effect on the metabolic and inflammatory aspects of morbid obesity
Nijhuis, J. (2008) · Research Publications (Maastricht University) · doi:10.26481/dis.20080625jn
Insulin resistance, genetic variation and cytokines; associations to myocardial infarction risk
Bennet, A. M. (2003) · Figshare
Carrero, J. J. (2008) · Figshare
The insulin-like growth factor system : Effects of circulating proteases
Gustafsson, S. (2005) · Figshare
PPAR β/δ, inflamació i resistència a la insulina en adipòcits
Marco, L. S. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Nishida, Y., Tokuyama, K., Nagasaka, S., Kiyonaga, A., Higaki, Y., Hara, M., Tanaka, K., & Tanaka, H. (2014) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2014.43007
Serrano, L., Michalik, L., Wahli, W., & Vázquez‐Carrera, M. (2012) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2012.09.010
Jové, M., Planavila, A., & Vázquez‐Carrera, M. (2005) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(05)73353-2 · Cited by 1
Coudriet, G. M. (2010) · D-Scholarship@Pitt (University of Pittsburgh)
STAT-3 and the liver: A new STATion on our way to understand diabetes?
Kortylewski, M., & Barthel, A. (2004) · Hepatology · doi:10.1002/hep.1840400432
Role of interleukin-6 in states of metabolic health and disease
Holmes, A. G. (2010) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27354477
Innate immune system and adiponectin in diabetic nephropathy in type 1 diabetes
Saraheimo, M. (2009) · Työväentutkimus Vuosikirja
On the genetic variation of interleukin-6 in health and coronary heart disease
Bennermo, M. B. (2005) · Figshare
Estrogen and liver X receptors in human disease
Nilsson, M. (2006) · Figshare
Sutinen, J. (2003) · Työväentutkimus Vuosikirja
The Effect of Manipulating the IL-6 Response to Exercise on Biomarkers and Exercise Performance
Walshe, I. H. (2012) · Northumbria Research Link (Northumbria University)
Lipid Microdomains in Insulin Receptor Signalling
Vainio, S. (2006) · Työväentutkimus Vuosikirja
Forero, M., & Antonio, S. (2006) · TDX (Tesis Doctorals en Xarxa)
Boyle, J. G. (2009) · Enlighten: Theses (The University of Glasgow)
Apical Periodontitis, inflammation and insulin resistance
(2015) · Inflammation and Cell Signaling · doi:10.14800/ics.1055
“Studies show that IL-6 reduces hepatic glycogen synthesis stimulated by insulin [45, 46] and decreases the transcription of IRS-1 and GLUT4 in adipocytes, reducing glucose uptake in adipose tissue ([47]).”
BackgroundAboryag, N. B., Mahmoud, A. M., & Ramadan, S. A. (2013)
Ahmed, H. M., Frhood, Q. K., & Alsahlawi, M. M. R. (2014) · Medical Journal of Babylon
Editorial Body shape, insulin resistance and inflammation: bridging diabetology and cardiology?
Després, J., Barter, P. J., & Sydney, A. (2010)
Barrett, T., Kim, J. K., Davis, R. J., Sabio, G., Zhang, Z., Jun, J. Y., Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M. A., et al. (2015)
Nascimento, M., & Ribeiro, R. (2012)
Bone Marrow Stem Cells and Bone Turnover in Diabetic Disease
McCabe, L. R., Raehtz, S., VanGelderen, C., & Rios‐Arce, N. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-16402-1_8
Baicalin Improves the IL-6-Mediated Hepatic Insulin Resistance in Hepa-1c1c7 Cells
Chae, B.-S., & Chanho, O. (2013) · Natural Product Sciences
Selvaraj, N. (2008) · INFLIBNET
Studies on the possible mechanisms behind the anti-diabetic effects of Xylitol.
Chukwuma, C. I. (2013) · ResearchSpace (University of KwaZulu-Natal)
Activation of opioid μ-receptors by loperamide to improve
Shien, P. T., Cheng, J., & City, T. (2005)
Milton, F. A. (2015) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2015.02.t.18077
Early Puberty: The Interplay among Obesity, Hormones, the Brain, and the Environment
Pope, S., & Lytle, S. (2015) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2015.20.6.1
Monocyte-macrophage dialogue with adipocytes : implication in human obesity-related type 2 diabetes
Hruskova, Z. (2016) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/65905
“In particular, IL6 expression by adipocytes has been considered to be one of the key inflammatory cytokines that promote insulin resistance (Kern et al., 2001; Rotter et al., 2003; Senn et al., 2002).”
BackgroundPGC-1 alfa como regulador inflamatório na esteato-hepatite não-alcoólica
Barroso, W. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2016.tde-06062016-125337
Metadata
- Authors
- Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A.
- Affiliations
- University of Rochester Medicine (US)
- ORCID
- Mooney, Robert A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2002-12-01
- Volume
- 51
- Issue
- 12
- Pages
- 3391-3399
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2130078845
- Cited by
- 883
- References
- 51
- Citations by year
- 2026: 27 · 2025: 19 · 2024: 22 · 2023: 29 · 2022: 28 · 2021: 41 · 2020: 42 · 2019: 31 · 2018: 31 · 2017: 36 · 2016: 49 · 2015: 46 · 2014: 46 · 2013: 34 · 2012: 39
- FWCI
- 23.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (PHS R01 38138)
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- interleukin-6, insulin resistance, hepatocytes, insulin receptor signaling, IRS-1 tyrosine phosphorylation, phosphatidylinositol 3-kinase, p85 regulatory subunit, Akt activation, glycogen synthesis, type 2 diabetes, inflammatory cytokines
- MeSH terms
- Animals, Cell Line, Dose-Response Relationship, Drug, Humans, Insulin, Insulin Resistance, Phosphoproteins, Phosphorylation, Proto-Oncogene Proteins, Receptor, Insulin, Time Factors, Tyrosine, Signal Transduction, Interleukin-6, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Hepatocytes, Proto-Oncogene Proteins c-akt, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review